Cargando…
PARP inhibitor-related haemorrhages: What does the real-world study say?
BACKGROUND: PARP inhibitors (PARPis) are novel molecular targeted therapeutics for inhibition of DNA repair in tumor cells, which are commonly used in ovarian cancer. Recent case reports have indicated that haemorrhages-related adverse events may be associated with PARPis. However, little is known a...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10008930/ https://www.ncbi.nlm.nih.gov/pubmed/36923428 http://dx.doi.org/10.3389/fonc.2023.1070343 |